EPIC 2024, April 18 - 19

McLeod Professor of Heart Valve Innovation, University of British Columbia Dr. Webb is the director of interventional cardiology at St. Paul’s Hospital, McLeod Professor at UBC, Medical Director of the Transcatheter Valve Program for the Province of BC. As director of the Centre for Heart Valve Innovation, he leads the group that developed the most widely used transcatheter aortic valve implantation procedures as well as many other first-in-human devices and procedures. He has performed or supervised over 3,000 aortic, mitral, pulmonary, and tricuspid valve procedures in over 30 countries throughout North America, Europe, and Australasia and has authored over 500 publications.

Adam Greenbaum, MD, joined Emory after serving at Henry Ford Heart and Vascular Institute in Detroit, Michigan for the past 19 years as Co-director of the Center for Structural Heart Disease, Director of the Cardiac Catheterization Laboratory and Director of the Interventional Fellowship Program. He has dedicated his career to patient care, clinical research and fellow and resident education. Dr. Greenbaum has received numerous patient care and teaching awards, and is recognized as a clinical expert in the field of structural heart disease. His breakthrough research surrounding structural heart problems and the minimally invasive techniques he developed as a result, gives patients new treatment options. And his novel transcatheter methods and approaches to valvular heart disease bring new hope to patients with no other options. He is board certified in general and interventional cardiology and is a Fellow of the American College of Cardiology, the American Heart Association and the Society for Cardiovascular Angiography and Interventions. Dr. Greenbaum graduated from the New York University School of Medicine in New York, NY. He completed his internal medicine training at the University of Michigan in Ann Arbor, MI and his general and interventional cardiology training at Duke University in Durham, NC.

David Hildick-Smith is an interventional Cardiologist of national and international renown. He undertakes procedures such as angioplasty, patent foramen ovale closure, atrial septal defect closure, left atrial appendage occlusion, transcatheter valve implantation and transcatheter mitral valve interventions. He does echocardiography onsite for relevant patients. He undertakes over 300 interventions per year at the Sussex Cardiac Centre and is Structural Heart lead for the British Cardiovascular Interventions Society.

Dr. Gaetano Paone is a member of the Emory Structural Heart and Valve Center, where he focuses on valve repair and replacement, coronary artery bypass graft surgery (CABG), transcatheter aortic valve replacement (TAVR), and other related, less invasive valve technologies. Dr. Paone earned his MD at New York University School of Medicine, and completed his general surgery residency at New York University Medical Center. After completing his thoracic surgery residency at the University of Illinois Hospitals, he joined the cardiothoracic surgery faculty at Boston University Medical Center. In 1990, Dr. Paone joined Henry Ford Hospital in Detroit. Dr. Paone also practiced at Crittenton Hospital Medical Center in Rochester, MI, from 2004-2009, and obtained his Masters in Health Service Administration from the University of Michigan School of Public Health in 2006. In 2009, he returned to Henry Ford Hospital, where he served as chief of the Division of Cardiac Surgery for nine years.

Jaffar is Director of Cardiovascular Innovation and Director of Interventional Electrosurgery at St Francis Hospital and Heart Center, Roslyn, NY. He performs research at the Laboratory of Cardiac Intervention, NHLBI, NIH. He led the invention of transcatheter electrosurgical techniques to cut heart tissue, and together with a team of dedicated physicians and creative thinkers, invented several novel transcatheter procedures and devices that have been translated into clinical practice. He received his undergraduate degree at Cambridge as a Scholar, medical degree at Oxford with merits, and an award-winning PhD in cardiovascular sciences at King’s College London. He completed training in Oxford, London, and Washington DC. He has written over 130 peer-reviewed manuscripts and has given over 50 invited lectures, including 4 late breaking clinical trial presentations. He is a regular live case operator.

Dr. James Harvey, MD, FACC is an Interventional Cardiologist with WellSpan Health. He attended undergraduate and graduate school at Vanderbilt University and then went to medical school at the University of South Florida College of Medicine. Dr. Harvey then did his residency training in Internal Medicine at Emory University Hospital in Atlanta, GA and completed fellowship training in both Cardiovascular Medicine and Interventional Cardiology at the Cleveland Clinic in Cleveland, OH where he served as the chief interventional fellow. Board-certified in Cardiovascular Medicine and Interventional Cardiology, Dr. Harvey has a special interest in structural and valvular heart disease, complex coronary artery disease, and mechanical cardiovascular circulatory support. He is the Director of the Cardiac Catheterization Laboratory and the Structural Heart Program at WellSpan York Hospital. He also serves as a member of the Executive Council for the Pennsylvania Chapter of the American College of Cardiology.

Dr. Patrick T. Gleason is an Assistant Professor at Emory University / Emory Healthcare, specializing in general non-invasive cardiology. He is part of the Emory Structural Heart and Valve team.

Dr. Paul Mahoney is the Director of the Structural Heart and Complex High Risk Intervention Programs at Sentara Health, a 14 Hospital System in Virginia and North Carolina. He has extensive clinical experience in transcatheter aortic and mitral valve replacement, mitral edge to edge repair, and left atrial appendage closure. He leads the complex high risk PCI team at Sentara Health. Dr. Mahoney has served as local PI in many clinical research trials including PARTNER, SURTAVI, TRILLUMINATE, TRISCEND, REPAIR MR, SMART TRIAL, OPTIMIZE PRO, EXCEL, PORTICO, APOLLO, EARLY TAVR, EXCEED, EXPAND, SYNTAX, M3 and dozens of others.

Philip Freeman is an Interventional Cardiologist & Senior Lecturer at the Aalborg University Hospital, Denmark

Dr Lederman is the chief of the Laboratory of Cardiovascular Intervention at the NHLBI Division of Intramural Research in Bethesda Maryland USA. His program creates new catheter treatments & devices for structural heart disease and introduces them into medical practice. His multidisciplinary team includes cardiologists, imaging physicists, and biomedical engineers. The NHLBI Lederman lab has created and translated into clinical practice several novel procedures including transcaval access to the aorta; mitral cerclage ventriculoplasty; LAMPOON, ELASTIC, and BASILICA leaflet modification to allow TMVR and TAVR; myocardial intramural navigation procedures including MIRTH ventriculoplasty, SESAME myotomy, and VINTAGE ablation; and MRI heart catheterization. These procedures and protocols are possible though a network of luminary collaborating structural heart interventional cardiologists.

Dr. Rogers is an interventional cardiologist and scientific lead for the MedStar Heart & Vascular Institute Structural Heart Disease program. He has a special interest in all aspects of minimally invasive treatment of structural heart disease, including Transcatheter Aortic Valve Replacement (TAVR), Transcaval access, Transcatheter Electrosurgery (LAMPOON and BASILICA techniques), para-valvular leak closure, percutaneous treatment of mitral valve regurgitation including Mitraclip and Transcatheter Mitral Valve Replacement (TMVR), LAA occluder, percutaneous pulmonary and tricuspid valve interventions, and cerebral protection devices for TAVR.

Zuyue Wang works at MedStar Washington Hospital Center, Washington, District of Columbia, USA.

Dr. Jai Khatri is Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He is Director of Complex Coronary Intervention at the Cleveland Clinic. His research and clinical focus is the management of coronary chronic total occlusions.

Dr. Kevin J. Croce is an interventional cardiologist and the director of the Chronic Total Occlusion Complex Percutaneous Coronary Intervention Program at Brigham and Women’s Hospital (BWH). He is an assistant professor of medicine at Harvard Medical School (HMS) who also directs the BWH Translational Discovery Laboratory which is a centralized research facility that uses state-of-the-art technology to perform preclinical testing of promising therapies and medical devices. Dr. Croce received his medical and Ph.D. degrees from Tufts University School of Medicine. He completed an internal medicine residency, a cardiology fellowship and an interventional cardiology fellowship at BWH. Dr. Croce is board certified in internal medicine, cardiovascular disease and interventional cardiology. His clinical interests include advanced treatments for obstructive coronary artery disease (CAD), and optimization of antithrombotic and antiplatelet pharmacotherapy. The author of over 50 peer-reviewed publications, Dr. Croce’s research focuses on understanding the molecular pathobiology of atherothrombotic (CAD) and on identifying new targets for CAD treatment. His research has received support from the National Institutes of Health.

Leah Raj, MD, earned her medical degree at the Emory University School of Medicine. She then completed her internal medicine residency at Emory University Hospital, followed by a cardiovascular medicine fellowship at the University of Southern California. Dr. Raj returned to Emory University Hospital to complete an interventional cardiology and complex high-risk interventional procedures (CHIP) fellowship. Dr. Raj’s interests include coronary artery disease, complex PCI, chronic total occlusions, mechanical circulatory support and pulmonary embolism management. Dr. Raj is also passionate about medical education and promoting women in intervention. Currently, she is a complex coronary and CTO operator at Vanderbilt University in Nashville.

Nicholas J. Lembo, MD, is an interventional cardiologist affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Howard University College of Medicine in Washington, DC. Dr. Lembo completed his internship and residency at Georgetown University Hospital in Washington, DC, a cardiology fellowship at the University of Texas Health Science Center in San Antonio, Texas and an interventional cardiology fellowship at the Andreas Gruentzig Cardiovascular Center, Emory University in Atlanta, Georgia.

Dr. Simon Walsh is a Consultant Cardiologist at the in Belfast who specialises in interventional cardiology. He has been involved in education for complex PCI and CTO PCI internationally for over a decade. Simon is also a keen researcher and has an extensive academic background, including multiple publications in the field of complex PCI.

Tony DeMartini is a cardiologist.

William Lombardi, MD, is a board-certified cardiologist, director of Complex Coronary Artery Disease Therapies in the Regional Heart Center Cardiology Clinic and a UW associate professor of Cardiology. Dr. Lombardi is an expert in cardiac catheterization and interventional cardiology. He strives to create active partnerships with his patients to achieve the best possible outcomes. His clinical interests include interventional cardiology and cardiac catheterization. He has focused much of his research efforts on developing and refining coronary chronic total occlusions and complex coronary artery procedures with great efficacy and reproducibility.

Dr. William Nicholson is acting Associate Professor of Medicine at Emory University School of Medicine and Director of Complex Coronary and Cardiac Intervention at Emory Healthcare. Dr. Nicholson also serves as the program director for the Advanced Complex High-Risk Interventional Procedures (CHIP) fellowship at Emory University Hospital. Dr. Nicholson came to Emory in 2020 after fourteen years in private interventional cardiology practice in York, Pennsylvania. While in private practice, Dr. Nicholson founded and developed that institution’s carotid stenting program, structural heart program, transcatheter aortic valve replacement program, and the complex coronary intervention program. He also has become nationally and internationally recognized for his expertise in treatment of Chronic Total Occlusions (CTO’s). He is a perennial live case operator for nationally televised conferences. Dr. Nicholson formerly trained at Emory University Hospital having completed his general cardiology and interventional fellowship in 2006. He completed his medical residency at Brown University Hospitals where he also served as Chief Medical Resident. He is a graduate of Pennsylvania State College of Medicine.

Adam Greenbaum, MD, joined Emory after serving at Henry Ford Heart and Vascular Institute in Detroit, Michigan for the past 19 years as Co-director of the Center for Structural Heart Disease, Director of the Cardiac Catheterization Laboratory and Director of the Interventional Fellowship Program. He has dedicated his career to patient care, clinical research and fellow and resident education. Dr. Greenbaum has received numerous patient care and teaching awards, and is recognized as a clinical expert in the field of structural heart disease. His breakthrough research surrounding structural heart problems and the minimally invasive techniques he developed as a result, gives patients new treatment options. And his novel transcatheter methods and approaches to valvular heart disease bring new hope to patients with no other options. He is board certified in general and interventional cardiology and is a Fellow of the American College of Cardiology, the American Heart Association and the Society for Cardiovascular Angiography and Interventions. Dr. Greenbaum graduated from the New York University School of Medicine in New York, NY. He completed his internal medicine training at the University of Michigan in Ann Arbor, MI and his general and interventional cardiology training at Duke University in Durham, NC.

G. Burkhard Mackensen, MD, PhD, FASE, is the Professor and Chair in the Department of Anesthesiology & Pain Medicine and the Allan J. Treuer Endowed Professor of Anesthesiology. He also serves as the Director of Interventional Echocardiography at the UW Medicine Heart Institute, and is an adjunct professor of Cardiology and Medicine. Dr. Mackensen is an internationally recognized expert in interventional and perioperative echocardiography, cardiothoracic anesthesiology, and critical care medicine. Dr. Mackensen earned his MD from the University of Hamburg, Germany and his PhD from the Technical University in Munich, Germany. His clinical interests include cardiothoracic and vascular anesthesiology, critical care medicine, and transesophageal & interventional echocardiography. His research interests include clinical outcomes after cardiothoracic surgery, the utility of three-dimensional (3) echocardiography in guiding catheter-based interventions and the value of 3D printing of the heart and its components.

George S. Hanzel, MD has joined Emory Healthcare and Emory University School of Medicine as an Associate Professor of Medicine. He is certified by the American Board of Internal Medicine in Cardiovascular Diseases and Interventional Cardiology. A graduate of Georgetown University School of Medicine in Washington, D.C., Dr. Hanzel completed his internship at the National Naval Medical Center in Bethesda, Maryland, his residency at Walter Reed Army Medical Center and then his cardiology fellowship at the National Naval Medical Center. Dr. Hanzel then served in the United States Navy, Lieutenant Commander, as a staff cardiologist at the Great Lakes Naval Hospital from 1999 to 2002. He completed an interventional cardiology fellowship in June 2004 at Beaumont Hospital in Royal Oak, Michigan. Dr. Hanzel then joined the Beaumont Hospital Royal Oak cardiology faculty in 2004 serving as Director of the Cardiac Catheterization Laboratory, Director of Structural Heart Disease, and associate professor at Oakland University William Beaumont School of Medicine until 2020. Dr. Hanzel's clinical and research interests include transcatheter aortic valve replacement, transcatheter therapies for mitral and tricuspid valve disease, alcohol septal ablation, and septal closure. Dr. Hanzel is a member of the STS/ACC Transcatheter Valve Therapy Registry Steering Committee and the Society for Cardiovascular Angiography and Interventions Structural Heart Disease Council.

Dr. Joe Xie is an Assistant Professor at Emory University / Emory Healthcare, specializing in general non-invasive cardiology. He is part of the Emory Structural Heart and Valve team.

Justin Strote is a medical doctor.

Dr. Patrick T. Gleason is an Assistant Professor at Emory University / Emory Healthcare, specializing in general non-invasive cardiology. He is part of the Emory Structural Heart and Valve team.

Dr. Scott Chadderdon, M.D., is an Associate Professor of Medicine in the Division of Cardiovascular Medicine at the School of Medicine in Portland, Oregon. He specializes in cardiac imaging, general cardiology, heart disease and diabetes, and heart valve conditions. He practices at OHSU Hospital - Marquam Hill Campus and is board certified in cardiovascular disease.

Dr. Stephen H. Little is the immediate past-president of the American Society of Echocardiography, and is the program director for the Cardiovascular Disease Fellowship program at Houston Methodist Hospital. His clinical interest is in Interventional Echocardiography. He is a professor of Medicine at Weill Cornell Medicine, and adjunct professor at Rice University, Dept. of Bioengineering. He holds the John S. Dunn Chair in Clinical Cardiovascular Research and Education. His research activities have focused on novel use of 3-D echocardiography for the quantification of native and prosthetic valve dysfunction.

Vasilis Babaliaros, MD is Professor of Medicine and Surgery at Emory University School of Medicine, and Co-Director of the Emory Structural Heart and Valve Center. He received his bachelor of science in biomedical engineering, summa cum laude, from Duke University, and his medical degree, magna cum laude, from Emory University. He also completed his training in Internal Medicine, Cardiology and Interventional Cardiology at Emory University. He received advanced training in valvular intervention under the direction of Alain Cribier at the University of Rouen, France before returning to Emory to join the faculty. His research interests include percutaneous cardiac valve repair and replacement as well as treatment of structural and congenital heart disease.

Bryan R. Kindya, MD, is an Interventional Cardiologist at Emory Healthcare and an Assistant Professor of Medicine at Emory University School of Medicine. He studied biomedical engineering at Duke University and received his medical degree from Emory University School of Medicine. He went on to complete his internal medicine residency, cardiology fellowship, interventional cardiology fellowship, and complex and high-risk interventional procedure (CHIP) fellowship at Emory as well before staying on as faculty. Bryan’s clinical focuses include complex coronary artery disease including chronic total occlusions, left main intervention, calcium modification, bifurcation disease, and mechanical circulatory support. He also has an interest in pulmonary embolism management and is a member of the Emory University Pulmonary Embolism Response Team, engaging in endovascular interventions for high-risk pulmonary disease. He is also involved in several cath lab quality projects, working to improve both cath lab efficiency as well as patient outcomes.

Catalin Toma, MD, is an interventional cardiologist and is certified in cardiovascular disease and interventional cardiology by the American Board of Internal Medicine. He currently serves as director of interventional cardiology for the Heart and Vascular Institute and director of the Interventional Fellowship at UPMC. He is an assistant professor of medicine at the University of Pittsburgh School of Medicine. He received his medical degree from Grigore T. Popa University of Medicine and Pharmacy in Iasi, Romania. Following a post-doctoral fellowship at Johns Hopkins in Baltimore, he completed an internal medicine residency at St. Luke’s Roosevelt Hospital Center in New York City and a fellowship in cardiovascular disease and interventional cardiology at UPMC. Dr. Toma joined the UPMC Heart and Vascular Institute in 2007. He currently leads the Chronic Total Occlusion Program as well as the Pulmonary Vascular Interventional Program at UPMC Presbyterian Hospital. He is an integral part of the Structural Heart Program with interests in the aortic and tricuspid space. Additional interests include intracoronary imaging and mechanical circulatory support. Dr. Toma has had an extensive amount of publications and presentations over his career, has several invention patents, and serves as a clinical study leader at local and national levels.

Leah Raj, MD, earned her medical degree at the Emory University School of Medicine. She then completed her internal medicine residency at Emory University Hospital, followed by a cardiovascular medicine fellowship at the University of Southern California. Dr. Raj returned to Emory University Hospital to complete an interventional cardiology and complex high-risk interventional procedures (CHIP) fellowship. Dr. Raj’s interests include coronary artery disease, complex PCI, chronic total occlusions, mechanical circulatory support and pulmonary embolism management. Dr. Raj is also passionate about medical education and promoting women in intervention. Currently, she is a complex coronary and CTO operator at Vanderbilt University in Nashville.

Mani A. Daneshmand, MD, is Associate Professor of Surgery in the Division of Cardiothoracic Surgery of the Department of Surgery at Emory University School of Medicine. Dr. Daneshmand serves as director of the Emory Heart & Lung Transplantation and Mechanical Circulatory Support Program and as director of the Emory ECMO (Extracorporeal Membrane Oxygenation) Program. A board certified cardiothoracic surgeon, his clinical interests include minimally invasive cardiac surgery, cardiac and pulmonary transplantation, mechanical circulatory support, and extracorporeal membrane oxygenation (ECMO).

Professor, Medicine, Lewis Katz School of Medicine at Temple University While maintaining his full medical and academic responsibilities at Temple University and the Temple University Hospital System, Dr. Bashir serves in an ex-officio Chief Medical Consultant capacity for Thrombolex, Inc. Dr. Bashir is also the co-inventor of the BASHIR™ Endovascular Catheter and serves as a Professor of Medicine at Temple University School of Medicine. His specialties include carotid artery and peripheral vascular diseases, as well as coronary and endovascular interventions (including carotid stenting and gene and stem cell therapy). He attended medical school at the University of Kashmir, Government Medical College in Srinagar, India. He has had fellowships at the Mayo Clinic, Tufts University School of Medicine, St. Elizabeth’s Medical Center and Nassau University Medical Center, SUNY at Stony Brook. His certifications include interventional cardiology, vascular technology, endovascular interventions, vascular medicine, cardiovascular disease, and internal medicine.

Dr. Aggarwal is an interventional and vascular cardiology physician in the Division of Cardiology at Henry Ford Hospital. His clinical expertise is in the area of pulmonary embolism and deep vein thrombosis. Most recently, he served as the director of interventional vascular medicine at University of Michigan. He lead the pulmonary embolism response team at Michigan Medicine as well as initiated and ran a very busy balloon pulmonary angioplasty program (one of the busiest nationwide and only one in the state of Michigan) for chronic pulmonary embolism and group 4 pulmonary HTN. His academic and research interests are centered around pulmonary embolism, chronic thrombo- embolic pulmonary hypertension.

Medical Director of the Cardiac Catheterization Laboratory, Emory University Hospital. Professor of Medicine, Emory University School of Medicine. Senior Physician, Emory University School of Medicine

Dr. Devireddy is an Associate Professor of medicine of Interventional Cardiology at Emory University. He received his medical degree from the University of Michigan in 1998 and completed Internal Medicine training at Duke University in 2001. In 2005, he completed fellowship training in both Cardiovascular Medicine and Interventional Cardiology at Emory University. He proudly joined the faculty upon completion of fellowship. Dr. Devireddy's primary focus is on patient-centered and thoughtful care of those suffering from the effects of cardiovascular disease. As an interventional cardiologist with nearly 15 years of experience, he understands that all patients are unique and require customized care. He is comfortable addressing highly complex cases requiring advanced diagnostic intuition and technical precision that are referred from throughout the Southeast U.S. Dr. Devireddy actively participates in the Interventional Cardiology research department, which has substantially contributed to many groundbreaking clinical trials. His individual research interests include structural heart and valvular disease, minimally invasive therapies to lower blood pressure, and novel solutions for complex cardiovascular disease. His work has led to multiple publications in leading medical journals.

Dennis Kim, MD, PhD is a board-certified interventional cardiologist for both pediatric and adult congenital heart patients, and serves as the Director of the Pediatric Cardiac Catheterization Labs at the Children’s Healthcare of Atlanta Heart Center. In addition to providing patient care, Dr. Kim holds an academic appointment, serving as a Professor of Pediatrics at the Emory University School of Medicine to train the next generation of pediatric cardiologists. Dr. Kim received his medical education at the University of Texas Medical Branch at Galveston and completed his residency in pediatrics at the University of Michigan in Ann Arbor, MI. Dr. Kim completed pediatric cardiology and pediatric interventional cardiology fellowships at the University of Michigan Congenital Heart Center, receiving focused training in advanced cardiac therapies and catheterization techniques. In his role as Director of the Pediatric Cardiac Catheterization Labs, Dr. Kim ensures that the Children’s Heart Center provides the full spectrum of diagnostic and interventional capabilities to deliver the best possible heart care to patients. He is skilled in interventional procedures and minimally invasive treatments for congenital heart disease, such as transcatheter valve replacement and septal defect repair, and is involved in a variety of clinical trials for new transcatheter device therapies.

Isida Byku, MD, FACC is an Assistant Professor of Medicine at Emory University, specializing in coronary and structural heart intervention. Dr. Byku also serves as the fellowship program director for the Structural Heart and Valve fellowship. After receiving her medical degree from Dartmouth Medical School, Dr. Byku completed residency training in internal medicine at the Johns Hopkins Hospital, followed by fellowship training in cardiovascular disease at the University of Chicago. She then came to Emory for a two-year fellowship in interventional cardiology and structural heart and valve disease, upon completion of which she joined as faculty. As a member of the cutting-edge structural team at Emory, Dr. Byku's areas of interest include advancements in the field of transcatheter therapies for structural heart and valve disease.

Dr. James Harvey, MD, FACC is an Interventional Cardiologist with WellSpan Health. He attended undergraduate and graduate school at Vanderbilt University and then went to medical school at the University of South Florida College of Medicine. Dr. Harvey then did his residency training in Internal Medicine at Emory University Hospital in Atlanta, GA and completed fellowship training in both Cardiovascular Medicine and Interventional Cardiology at the Cleveland Clinic in Cleveland, OH where he served as the chief interventional fellow. Board-certified in Cardiovascular Medicine and Interventional Cardiology, Dr. Harvey has a special interest in structural and valvular heart disease, complex coronary artery disease, and mechanical cardiovascular circulatory support. He is the Director of the Cardiac Catheterization Laboratory and the Structural Heart Program at WellSpan York Hospital. He also serves as a member of the Executive Council for the Pennsylvania Chapter of the American College of Cardiology.

Dr. James (Jamie) McCabe graduated magna cum laude from Bowdoin College and received his medical degree from Yale University. He completed 10 years of post-medical school training including internal medicine training and general cardiology fellowship at University of California, San Francisco (UCSF) and interventional cardiology fellowship as well as an advanced interventional fellowship in structural and peripheral treatments at Brigham and Women's Hospital / Harvard Medical School. He is board certified in Internal Medicine, Cardiology, and Interventional Cardiology. Dr. McCabe is currently the Section Chief of Interventional Cardiology and Medical Director of the Cardiac Cath Labs at the University of Washington in Seattle, WA. He is a nationally recognized clinician educator and investigator in transcatheter therapies for valvular heart disease and coronary artery intervention.

Dr Mullen is a consultant cardiologist with the NHS, based at the Barts Heart Centre in London. He is internationally recognised for his expertise in the treatment of structural heart disease, with nearly 20 years of experience in this field. His private practice is based at the Harley Street Clinic and Barts Heart Centre, where he is the clinical lead for structural heart intervention. Previously, he was director of the cardiac catheter laboratories at the Royal Brompton and Harefield NHS Trust. He has played a key role in the development of new technologies for the treatment of conditions such as valvular heart disease, patent foramen ovale (PFO), atrial septal defect (ASD) and aortic coarctation and their introduction into the UK. These technologies include transcatheter aortic valve implantation (TAVI), MitraClip, Cardioband and suture closure of patent foramen ovale. Dr Mullen has a broad research portfolio, leading and participating in numerous clinical trials. He is frequently invited to give lectures and live demonstrations at national and international conferences.

Ronald Allen Ligon, MD, is a pediatric and adult congenital interventional cardiologist at the Children’s Healthcare of Atlanta Heart Center and is an assistant professor at Emory University School of Medicine. He received his undergraduate degree in Exercise and Sport Science from the University of Georgia. He attended medical school at Mercer University School of Medicine in Savannah, and then completed a pediatrics residency at Atrium Health: Levine Children’s Hospital. He completed requirements for designation as a Fellow of the Academy of Wilderness Medicine, then pediatric and interventional cardiology/catheterization fellowships at Emory University - Children’s Healthcare of Atlanta. He is board certified in general pediatrics, pediatric cardiology, and adult congenital heart disease. Dr. Ligon works with pediatric as well as adult congenital heart disease patients and performs interventional catheter-based procedures. He remains involved in clinical outcomes research and the development of innovative minimally-invasive procedures and technologies. He believes it is an honor and a privilege to help a patient and family navigate life with congenital heart disease and the process of undergoing any cardiac procedure. At the center of his work remains the goal for all congenital heart disease patients to live their longest, most quality life, and he believes that minimally-invasive catheterization procedures can help many achieve that goal.

Dr. Stephen H. Little is the immediate past-president of the American Society of Echocardiography, and is the program director for the Cardiovascular Disease Fellowship program at Houston Methodist Hospital. His clinical interest is in Interventional Echocardiography. He is a professor of Medicine at Weill Cornell Medicine, and adjunct professor at Rice University, Dept. of Bioengineering. He holds the John S. Dunn Chair in Clinical Cardiovascular Research and Education. His research activities have focused on novel use of 3-D echocardiography for the quantification of native and prosthetic valve dysfunction.

Vasilis Babaliaros, MD is Professor of Medicine and Surgery at Emory University School of Medicine, and Co-Director of the Emory Structural Heart and Valve Center. He received his bachelor of science in biomedical engineering, summa cum laude, from Duke University, and his medical degree, magna cum laude, from Emory University. He also completed his training in Internal Medicine, Cardiology and Interventional Cardiology at Emory University. He received advanced training in valvular intervention under the direction of Alain Cribier at the University of Rouen, France before returning to Emory to join the faculty. His research interests include percutaneous cardiac valve repair and replacement as well as treatment of structural and congenital heart disease.

Bryan R. Kindya, MD, is an Interventional Cardiologist at Emory Healthcare and an Assistant Professor of Medicine at Emory University School of Medicine. He studied biomedical engineering at Duke University and received his medical degree from Emory University School of Medicine. He went on to complete his internal medicine residency, cardiology fellowship, interventional cardiology fellowship, and complex and high-risk interventional procedure (CHIP) fellowship at Emory as well before staying on as faculty. Bryan’s clinical focuses include complex coronary artery disease including chronic total occlusions, left main intervention, calcium modification, bifurcation disease, and mechanical circulatory support. He also has an interest in pulmonary embolism management and is a member of the Emory University Pulmonary Embolism Response Team, engaging in endovascular interventions for high-risk pulmonary disease. He is also involved in several cath lab quality projects, working to improve both cath lab efficiency as well as patient outcomes.

Jai Khatri is a cardiologist at Cleveland Clinic, Cleveland, OH, USA.

Dr. James (Jamie) McCabe graduated magna cum laude from Bowdoin College and received his medical degree from Yale University. He completed 10 years of post-medical school training including internal medicine training and general cardiology fellowship at University of California, San Francisco (UCSF) and interventional cardiology fellowship as well as an advanced interventional fellowship in structural and peripheral treatments at Brigham and Women's Hospital / Harvard Medical School. He is board certified in Internal Medicine, Cardiology, and Interventional Cardiology. Dr. McCabe is currently the Section Chief of Interventional Cardiology and Medical Director of the Cardiac Cath Labs at the University of Washington in Seattle, WA. He is a nationally recognized clinician educator and investigator in transcatheter therapies for valvular heart disease and coronary artery intervention.

Dr. Kevin J. Croce is an interventional cardiologist and the director of the Chronic Total Occlusion Complex Percutaneous Coronary Intervention Program at Brigham and Women’s Hospital (BWH). He is an assistant professor of medicine at Harvard Medical School (HMS) who also directs the BWH Translational Discovery Laboratory which is a centralized research facility that uses state-of-the-art technology to perform preclinical testing of promising therapies and medical devices. Dr. Croce received his medical and Ph.D. degrees from Tufts University School of Medicine. He completed an internal medicine residency, a cardiology fellowship and an interventional cardiology fellowship at BWH. Dr. Croce is board certified in internal medicine, cardiovascular disease and interventional cardiology. His clinical interests include advanced treatments for obstructive coronary artery disease (CAD), and optimization of antithrombotic and antiplatelet pharmacotherapy. The author of over 50 peer-reviewed publications, Dr. Croce’s research focuses on understanding the molecular pathobiology of atherothrombotic (CAD) and on identifying new targets for CAD treatment. His research has received support from the National Institutes of Health.

Leah Raj, MD, earned her medical degree at the Emory University School of Medicine. She then completed her internal medicine residency at Emory University Hospital, followed by a cardiovascular medicine fellowship at the University of Southern California. Dr. Raj returned to Emory University Hospital to complete an interventional cardiology and complex high-risk interventional procedures (CHIP) fellowship. Dr. Raj’s interests include coronary artery disease, complex PCI, chronic total occlusions, mechanical circulatory support and pulmonary embolism management. Dr. Raj is also passionate about medical education and promoting women in intervention. Currently, she is a complex coronary and CTO operator at Vanderbilt University in Nashville.

Nicholas J. Lembo, MD, is an interventional cardiologist affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Howard University College of Medicine in Washington, DC. Dr. Lembo completed his internship and residency at Georgetown University Hospital in Washington, DC, a cardiology fellowship at the University of Texas Health Science Center in San Antonio, Texas and an interventional cardiology fellowship at the Andreas Gruentzig Cardiovascular Center, Emory University in Atlanta, Georgia.

Dr. Pratik Sandesara is an interventional cardiologist at Emory University Hospital and an assistant professor of medicine at Emory University School of Medicine. His clinical focus is on complex and high-risk percutaneous coronary intervention including chronic total occlusion revascularization.

Tanveer Rab is an interventional cardiologist at Emory University School of Medicine, Atlanta, GA, USA.